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ABSTRACT
Multiple Sclerosis (MS) is a neurological disease where the immune system attacks the myelin
sheath of neuron axons leading to considerable symptoms. The disease has detrimental effects on
patients’ health-related quality of life (HRQoL). This study assesses the quality of life (QoL) of MS
patients receiving medical care at Palestinian Ministry of Health’s (PMoH) directorate in the West
Bank. 150 patients were included, with ages between 20 and 65 years. A standardized questionnaire
was used, it is divided into 2 sections: the first section with questions on basic demographic and
socio-economic characteristics; the second focuses on the patient’s QoL by assessing physical,
mental and emotional health’s factors. The MSQoL-54 scale scores were created using the Likert
method by averaging items within the scales. Then the row scores were linearly transformed into 0–
100 scales. Calculation of the score of physical health composite and the mental health composite,
and multiplying these constructed variables by the weight given to each variable and finding subtotals
for each composite. Patients had a mean age of 35 years. 68.7% were females. 99.3 % were diagnosed
as with Relapsing Remitting Multiple Scleroses (RRMS). Overall quality of life mean was
58.71(standard deviation (SD): 22.06), role limitations due to physical and emotional problems
means: 32(SD: 39.51) and 32(SD: 40.11) respectively, and health distress mean: 3.19 (SD: 1.38).
Both physical and mental health composite mean were: 40.94(SD: 38.97) and 39.91(SD: 36.67)
respectively. All patients had low physical and mental HRQoL scores. The most affected parts of
QoL in the sample were those related to role limitations due to physical and emotional problems,
physical function, emotional well-being, fatigue, and health perception. Health distress was found to
be the most powerful predictor of QoL of MS patients. The results are beneficial to the PMoH in
developing plans to improve the quality of life of MS patients.
Keywords: Multiple Sclerosis, Quality of Life, Neurological Disease, Relapsing Remitting
Multiple Scleroses.
23.5 and 30 years, respectively. Incidence is
INTRODUCTION
low in childhood, increasing rapidly after age
Multiple Sclerosis (MS) is one of the
18 [7-9]. Even though the cause of the disease
most common neurological diseases [1]. This
is still unknown[5] there is a complex of
disease is detected by the presence of
genetic and environmental factors related to
multifocal spots of demyelination in the
the occurrence of this disease [10]. One of the
central nervous system [1, 2], in which the
genetic factors in the development of this
immune system attacks the myelin sheath of
disease is Zn deficiency, which affects several
axons in neurons [3, 4] causing neurological
functions in the immune system [1, 5].
disability in young adults [5, 6]. MS is
Environmental factors include bacterial or
relatively common in Europe, the United
viral infections that cause T-cells to confuse
States, Canada, New Zealand [[7]. It is
myelin proteins for these antigens [4].
affecting 2 million people worldwide with
Occupational exposure to sunlight which may
350,000 people in the United States alone [8].
lead to the occurrence of multiple sclerosis
The risk of disease is greater in women than in
[10]. There are studies showing that vitamin D
men [7]. Median and mean age of onset were
intake by regular fish consumption and cod
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liver oil has a positive impact on the
prevention of this disease progression, this has
been observed in a recent Norwegian casecontrol study. [11]. However, there are no
prospective studies confirming that vitamin D
deficiency is a risk factor for multiple
sclerosis [12]. There is also an association
between smoking and MS, where the
relationship is dose-response, in which an
increased frequency of smoking will increase
the progression of MS in both males and
females [13, 14]. MS is generally divided into
three clinical subtypes; 1- RelapsingRemitting Multiple Sclerosis (RRMS),
periods of neurological dysfunction followed
by complete or incomplete remission, 2Secondary
Progressive
(SPMS)
(uninterrupted progression), 3- Primary
Progressive (PPMS), as MS can begin in some
of the patients with a progressive disease
course [2, 5]. The diagnosis of this disease is
based on clinical findings and Magnetic
Resonance Imaging (MRI). There are some
considerable symptoms
across multiple
sclerosis patients, including loss of function
or feeling in the limbs , loss of bowel or
bladder control , sexual dysfunction , fatigue,
blindness due to optic neuritis, double vision,
loss of balance, pain, loss of cognitive
functioning, and emotional changes [4]. The
first sign of the onset of the disease is urinary
disorder, which has been found to occur in 2%
to 10% of multiple sclerosis patients [15].
MS disorder was found to have
detrimental effects on patients’ health-related
quality of life (HRQoL) [16]. Globally, The
World Health Organization (WHO), has
defined quality of life (QOL) as: “the
individual's perception of his/her position in
life in the context of the culture, the value
systems in which he/she lives, and in relation
to his/her goals, expectations, standards and
concerns [17]. According to several studies
and by comparing with other chronic medical
illnesses, the quality of life includes several
domains: physical, social, and emotional
aspects to determine the patient’s satisfaction
level with life [16]. It is worth to mention that
a proper assessment of (HRQoL) can only be
assessed by the patients themselves, not by the
physicians [18]. Researchers found many
aspects to affect the quality of life through MS
patients’ lifespan. As it can be seen in MS

patients who
have a shorter lifespan
compared to matched age and sex individuals
[19]. However, when MS patients become
older, they may face different problems than
younger individuals, which leads them to feel
depressed affecting both the mental and
physical domains of HRQoL, due to impaired
motivation, interest, limited physical progress,
limited social support, changes in
relationships, and decreased accessibility to
the environment. [19, 20]. Education and
employment may decrease the chances of
being mentally destroyed [19].
Moreover, damaging of different cells in
the brain which causes fatigue, functional
limitations that affect daily activities[17]. A
study conducted in Germany, France, and the
United Kingdom showed that QoL was
significantly different among the control
group and those who had MS disease, in
which physical functions including; self-care,
walking indoors, shopping, use of public
transport, running, and lifting heavy objects,
in addition to general wellbeing were 40%50% less than the control group. Moreover,
psychological function and social role
functions were 20% lower than in the control
group [21]. Psychological symptoms
experienced by MS patients were anxiety,
depression, cognitive decline, irritability, and
anger [16].
The importance of the treatment is to
avoid temporary disability due to relapses,
delay disease progression of multiple
sclerosis, and to avoid permanent disability
[22], for that treating patients with early
diagnosis was considered more beneficial to
the patients and society [22].
Assessing the quality of life (QoL) among
MS patients is still essential, as it helps in
measuring and monitoring
challenging
symptoms, treatments, side-effects [18], and
encourages successful treatment by health
care providers [23].A low awareness about
MS complications is considered an important
issue that may contribute to MS patients who
live in the West Bank, suffering from this
disease, thus, affecting their QoL. Therefore,
it is necessary to focus on the main
difficulties/challenges that MS patients face
and suffer from, to relive their serious physical
and psychological problems.
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METHODS

Instrument

Research Question

The measurement instrument aimed to
assess the quality of life and its associated
factors among MS patients who are receiving
medical care at the health centers of the MoH.
A standardized questionnaire was used with
minor modifications to suit the Palestinian
context. “Multiple Sclerosis Quality of Life
(MSQOL)-54 Instrument “ [24]. It is an
appropriate measuring tool for assessing
health-related quality of life; in addition,
patients' demographic characteristics were
collected.

How is the quality of life of Multiple
Sclerosis (MS) patients receiving medical care
in the Palestinian Ministry of Health’s (MOH)
directorate in the West Bank and associated
factors?
Sub-research questions
1. What is the quality of life of a sample of
MS Palestinian patients in the West Bank?
2. What are the factors associated with the
quality of life of this sample of MS
patients?
Study design
This is a quantitative cross-sectional
study covering all MS patients (200) receiving
medical care at the MOH’s directorate and
living in the West Bank during the period
between March to December in 2019.
Sampling
We collected data from all districts
(Jerusalem, Bethlehem, Hebron, Ramallah,
Nablus, Salfeet, Qalqelya, Tubas, Jeneen, and
Jericho). We then divided the district into 3
strata, north, middle, and south.
Pharmacists who work in (MoH)
directorates distributed the questionnaires to
the MS patients and helped when necessary.
The total population of MS patients
receiving medications from the Ministry of
Health (MoH) clinics in the West Bank was
200. Of those, 150 patients were willing to
join this study at 75% of all patients. We
obtained 43 cases from the North of the West
Bank (28.7%) of all cases), 68 from the
middle of the West Bank (45.3% of all cases),
and 39 from the South West Bank (26%) of all
cases). Inclusion criteria included patients
diagnosed with MS diseased, that was
confirmed by a neurologist, with the existence
of clinical symptoms, and the indication of the
presence of the lesion in the central nervous
system, and received medication in (MoH)
directorates [17]. Exclusion criteria MS
patients who are not receiving medication
from (MoH) clinics in the West Bank.

The self-administered questionnaire is
divided into 2 sections: the first section
encompasses a series of brief questions to
ascertain basic demographic and socioeconomic characteristics, data related to age,
sex, marital status, education level, income,
employment, residence, the second section
focuses on the patient’s quality of life by
assessing physical health, role limitation due
to physical health problems, role limitations
due to emotional problems, pain, emotional
well- being, energy, health perception, social
function, cognitive function, health distress,
sexual function, change in health, satisfaction
with sexual function, and overall quality of
life. The Questions also included the date
when multiple sclerosis was diagnosed, the
availability of MS medications at the (MoH)
directorate, and compliance to treatment.
Statistical analysis
Univariate analyses were initially
performed; using frequencies for categorical
variables, mean and standard deviation for
continuous variables. Bivariate analysis was
used to identify significant demographic and
socio-economic factors related to the
dependent variable, chi-square (chi-2) for
categorical variables and the Independent Ttest for continuous variables. SPSS V.22 was
used for statistical analysis.
The MSQoL-54 scale scores were created
using the Likert method by averaging items
within the scales, and then the row scores were
linearly transformed into 0–100 scales to
clarify the factors that affect the quality of life
of MS patients. Higher score indicates better
quality of life.
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Using the constructed variable overall
quality of life after Likert analysis as the
cutoff point to assess the quality of life in all
domains, and the average calculation of any
item related to physical and mental health was
considered good if it is higher than this point,
and bad if it is less than this point.
We calculate the score of physical health
composite included (physical function, health
perceptions, energy/fatigue, role limitations –
physical pain, sexual function (M+W), social
function, health distress) and mental health
composite included (health distress, overall
quality of life, emotional well-being, role
limitations – emotional, cognitive function)
after multiplying these constructed variables
by the weight were given to each variable and
find the subtotal of each composite as shown
in the table below, this is to determine how are
all physical and mental health aspects can
affect quality of life.
The internal reliabilities of MSQoL-54
were assessed on multiple item scales by using
Cronbach’s alpha coefficient, which ranges
from 0–1, where 1 means perfect reliability.
Ethical issues
1.

was obtained to conduct the study on MS
patients receiving medical care at the
PMoH Directorate.
2.

Full consent was obtained from all
participants prior to starting the
questionnaire, and their confidentiality
was ensured.

RESULTS
In the sample of 150 MS patients
receiving medications from the Ministry of
Health (MoH) clinics in the West Bank,
68.7% were females, 55.3% were 35 years
old or less, 28.7% lived in the north of
Palestine, 45.3% in the middle of Palestine
,and 26% in the south of Palestine, 52% had a
university degree, 67.3% were married, the
majority of the study population (76% ) had a
monthly income equating the average wages
in Palestine, 51.3% were unemployed , 54.7%
live in cities, 72.7 % of patients were
diagnosed with MS early whine the first year
of the appearance of symptoms, 84.7% toke
medication regularly, 50.7% of patients
benefitted from medication, 99.3 % of the
sample were diagnosed with Relapsing
Remitting Multiple Scleroses (RRMS).

Approval from the primary health care of
Palestinian Minister of Health (PMoH)

Table )1(: Frequency of all demographic and clinically variables.
Variable name
Female
Sex
Male
Age (year)
Mean(SD)
35 years or less
Age category
Above 35 years
North
District
Middle
South
Less than secondary
Education
Secondary
Post-secondary
Single
Marital status
married
Widow / divorced
Less than others
Evaluate your income compared
As others
to the people around you
More than others

Statistical summary
103(68.7%)
47(31.3%)
35.05(10.90)
83(55.3%)
67(44.7%)
43(28.7%)
68(45.3%)
39(26%)
42(28%)
30(20%)
78(52%)
41(27.3%)
101(67.3%)
8(5.3%)
33(22%)
114(76%)
3(2%)
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Variable name
Student
Employment status
Unemployment
Employment
Camp
Residence
Village
City
Early within the first year of A the
appearance of symptom
Discovered disease
Late after one year of the appearance
of symptom
Yes
Take medication regularly
Some time
No
Yes
Medicine has positive effect on
Some time
your health
No
relapsing Remitting
MS classification
Secondary progressive
Used overall quality of life as cut-off
point, mean and SD 58.38(22.15), role
limitations due to physical and emotional
problems 32(39.51), 32(40.11) respectively,
physical function 35.8(20.82), emotional

Statistical summary
13(8.7%)
77(51.3%)
60(40%)
7(4.6%)
61(40.7%)
82(54.7%)
109(72.7%)
41(27.3%)
127(84.7%)
20(13.3%)
3(2%)
76(50.7%)
66(44%)
8(5.3%)
149(99.3%)
1(.7%)

well-being
45.94(17.88),
fatigue
40.74(17.91), health perception 42.86(21.80),
and health distress 3.19(1.38). Both physical
and mental health composite 40.93(38.97),
39.84(36.67) respectively.

Table (2): MSQOL-54 Scoring Form, mean and SD of all constructed variables.
Item
1
2
3
4
5
6
7
8
9
10

11
12
13
14

Physical function
Role limitations due to physical
problems
Role limitations due to emotional
problems
Pain
Emotional well-being
Energy/fatigue
Health Perceptions
Social function
Cognitive function
Health distress
Sexual function men +
Sexual function women
Sexual function M&W
Change in health
Satisfaction with sexual function
OVERALL QUALITY OF LIFE

Cronbach’s
alpha
.911

NO. of
item
10

Mean

SD

35.80

20.82

32

39.51

.869

4

32

40.11

.828

3

56.35
45.94
40.74
42.86
57.65
52.60
3.19
69.36
66.79
67.59
52.87
56.77
58.71

22.06
17.88
17.91
21.80
21.10
27.89
1.38
34
32.90
00
22.49
30.24
22.06

.642
.664
.737
.827
.516
.909
.932
.937
.925

3
5
5
5
3
4
4
4
4

a
a
.837

1
1
2

SD-standard deviation
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Table (3): Calculating MSQOL-54 Physical Health Composite Score.
MSQOL-54 Scale
Physical function
Health perceptions
Energy/fatigue
Role limitations - physical
Pain
Sexual function (M+W)
Social function
Health distress

Final Scale Score
35.80
42.86
40.74
32
56.35
67.59
57.65
3.19

* (Weight )
.17
.17
.12
.12
.11
.08
.12
.11

Subtotal
6.08
7.28
4.88
3.84
6.20
5.40
6.91
.35
40.94

Table (4): Calculating MSQOL-54 Mental Health Composite Score.
MSQOL-54 Scale
Health distress
Overall quality of life
Emotional well-being
Role limitations - emotional
Cognitive function

Final Scale Score
3.19
58.71
45.94
32
52.60

*Weight
.14
.18
.29
.24
.15

Subtotal
.44
10.56
13.32
7.68
7.9
39.91

Table (5): Descriptive statistics MSQOL-54 Composite Score.
Item
Physical Health Composite
Mental Health Composite

Mean
40.94
39.91

SD
38.97
36.67

SD-standard deviation.

The percentage of those who have good
quality of life among patients who live in the
middle of Palestine was 43(63.2%), compared
to those who live in the north and south of
Palestine, 28(65.1%), 11(28.2%) respectively,
[chi-2=14.929, p=.001]. Among those who
had a monthly income equating the average
wage in Palestine 70(61.4%), compared to
those who had a monthly income less or more
than the average wage in Palestine
11(33.3%),1(33.3%), respectively, [ chi2=8.699, p= .013]. Among those who live in
cities 51(62.2%), compared to those who live
in camps and villages, 1(14.3%),51(62.2%),
respectively, [ chi-2= 7.222, p=.027], Among
those who were diagnosed early within the
first year of the appearance of symptoms
69(63.3%) compared to those who were
diagnosed
late after one year from the
appearance of symptoms 13(31.7%), [chi2=12.001, p=.001]. Among those who were
taking medication regularly, 75(59.1%),

compared with those who were taking
medication irregularly or not taking
medication
at
all,
5(25%),2(66.7%),
respectively [chi-2=8.264, p=.016].
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Table (6): Bivariate analysis.
variable name
Sex
Age
District

Education

Marital status
Evaluate your
income
compared to the
people around
you
Employment
status

Residence

Diagnose
disease

Take
medication
regularly
Medicine has
positive effect
on your health
MS
classification

Male
Female
35 years and less
Above 35 years
North
Middle
South
Less than
secondary
Secondary
Post-secondary
Single
Married
Widow /
divorced
Less than others
As others

Quality of life of MS
patients
Good
Bad
22(46.8%)
25(53.2%)
60(58.3%)
43(41.7%)
51(61.4%)
32(38.6%)
31(46.3%)
36(53.7%)
28(65.1%)
15(34.9%)
43(63.2%)
25(36.8%)
11(28.2%)
28(71.8%)
23(54.8%)

19(45.2%)

16(53.3%)
43(55.1%)
26(63.4%)
51(50.5%)

14(46.7%)
35(44.9%)
15(36.6%)
50(49.5%)

5(62.5%)

3(37.5%)

11(33.3%)
70(61.4%)

22(66.7%)
44(38.6%)

More than others

1(33.3%)

2(66.7%)

Student
Unemployment
Employment
Camp
Village
City
Early before one
year from
symptom
Late after one
year from
symptom
Yes
Some time
No
Yes
Some time
No
Relapsing
Remitting
Secondary
progressive

11(84.6%)
38(49.4%)
33(55%)
1(14.3%)
30(49.2%)
51(62.2%)

2(15.4%)
39(50.6%)
27(45%)
6(85.7%)
31(50.8%)
31(37.8%)

69(63.3%)

40(36.7%)

13(31.7%)

28(68.3%)

75(59.1%)
5(25%)
2(66.7%)
46(60.5%)
34(51.5%)
2(25%)

52(40.9%)
15(75%)
1(33.3%)
30(39.5%)
32(48.5%)
6(75%)

81(54.4%)

68(45.6%)

1(100%)

00

Pearson Chi 2 test
Chi 2 test

P value

1.706

.192

3.446

.063

14.929

.001

.028

.986

2.173

.337

8.699

.013

5.586

.061

7.222

.027

12.001

.001

8.264

.016

4.159

.125

.835

.361
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DISCUSSION
The purpose of this study is to assess the
quality of life and its associated factors for MS
patients who are receiving medical care at the
health centers of PMoH in West Bank directorate.
QoL measures not only relate to happiness and
satisfaction, but have also become an important
factor in the manifestation of disease outcomes,
patient care, management, and improving function
in society. [25, 26] For that we have used a selfadministered questionnaire (Multiple Sclerosis
Quality of Life (MSQOL)-54 Instrument ) [24].
The instrument was easy to administer and was
well accepted by 75% of our sample of MS
patients. The average time to complete the
questionnaire was from 5 to 15 minutes, the
questionnaire was not difficult to understand, and
similar results were found in other studies, where
the average time to complete the questionnaire
was from 4 to 20 minutes [7, 9]. Most of the
patients were able to complete the questionnaire
without any intervention by the research team, only
a small percentage of patients who were
uneducated needed assistance from a pharmacist.
In our study, we found the internal
consistency reliability index for these scales to be
(0.877) by conducting the coefficient of stability
Cronbach’s alpha test. The Internal reliabilities of
the instrument ranged from (0.516) on social
function to (0.937) on sexual function for men.
MSQoL-54 scales were reliable in MS Palestinian
patients in the West Bank as elsewhere [9].
We found that MS patients suffer from a low
score in overall quality of life with mean:
58.38(SD: 22.15), patients also had a score below
the recommended cut-off point (overall quality of
life) in the following domains: role limitations due
to physical and emotional problems with means:
32(SD: 35.8) and 32(SD:40.11) respectively,
physical function mean: 35.8(SD: 20.82),
emotional well-being mean: 45.94(17.88), fatigue
mean: 40.74(SD: 17.91), health perception mean:
42.86 (SD:21.80), and health distress mean: 3.19
(SD: 1.38).Both physical and mental health
composite
mean:
40.93(SD:38.97)
and
39.84(SD:36.67) respectively. Similar lower
physical and mental components of the QoL scores
were also found in MS patients in Bosnia and
Herzegovina, Slovenian, and Italy.[2-4] The
previous literature has shown that the lower
quality of life was a result of some physical and
psychological conditions which affect MS patients
negatively and so exacerbate the disease effect [27,
28].
51.3% of MS patients in our sample were
unemployed due to the variety of different

symptoms that MS patients suffer from, including:
fatigue and functional limitations which affect
daily activities [17], loss of function or feeling in
the limbs, loss of balance, pain, loss of cognitive
function, and emotional changes [4]. As a
consequence of these symptoms, patients were
unable to work and became dependent on others.
We found that health distress in our sample
had a major inﬂuence on HRQOL. As in the
literature, patients with MS had impaired
motivations, interest, and collaboration, and felt
restricted from participating in social life and
family relationships, leading to mental problems
among MS patients [17]. While sexual function
and satisfaction of sexual function had higher
scores than the cutoff point, this may be due to the
reason that most patients were not willing to
answer the questions related to this subscale,
resulting in missing data.
(71.8%) of patients who were from the south
had bad quality of life, this percentage is higher
than those patients who were from the middle and
north of Palestine (36.8%) (34.9%) respectively,
there is no clear explanation for this; however, it
may be due to the bad status of all patients who
participated from the south.
In our sample, we found younger patients to
have better quality of life than older patients, this
is similar to previous studies [7, 29]. Younger
patients have more hope and optimism to face the
disease in early stages [29]. Elderly patients may
face different problems than younger individuals,
which may lead them to suffer from depression
affecting both the mental and physical domains of
HRQoL, impaired motivations, interest, limited
social support, and changes in relationships [19,
20].
Among our sample of MS patients, we found
that those who had an early diagnosis of the disease
and took medications regularly had better quality
of life. As in the previous literature, early
diagnosis of the disease and treatment were
considered more beneficial to the patients and
society, which prevents the progression of the
disease, avoiding severe cases, and permanent
disability [22].
The Strength of this study: it is the first study
conducted to assess the quality of life of MS
patients in Palestine –West Bank.
The limitations of this study: not all patients
were willing to join this study, only 75% of MS
patients receiving treatment in MoH in West Bank
agreed to complete the questionnaire. The sample
size is too small, 150 patients, it is can’t generalize
the result globally.
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We sent a questionnaire to all districts
according to the number of MS patients in each
district but not all patients willing to join this study,
especially in the south, where 68 (45.3%) of the
patients were from the middle of the West Bank,
43 (28.7 %) were from the north and 39 (26%)
were from the south. We attribute this to the
difference in the culture of patients from the
middle to the north and south of West Bank in
terms of disclosing and talking about the disease
due to embarrassment. Pharmacists in the south
directorate had some difficulty in convincing
patients to fill the questionnaire, because patients
in the south had a fear of disclosing their illness
and suffering. For the subscales sexual function
and satisfaction of sexual function caused
embarrassment for some patients as found in other
studies [8, 9], 28.6% of our sample had no desire
to answer these questions, especially in single
patients who have no experience in this domain.
Self-administrated questionnaires may lead to
information bias as some of the questions could not
be well understood, which might have an impact
on measuring the variables of interest.
CONCLUSIONS
This study highlighted the importance of
assessing the QoL of MS patients in the oPt. All
patients had low physical and mental HRQoL
scores. The most affected parts of QoL in the
sample were those related to role limitations due to
physical and emotional problems, physical
function, emotional well-being, fatigue, and health
perception. Health distress was found to be the
most powerful predictor of QoL of MS patients.
The results are beneficial to the PMoH in
developing plans to improve the quality of life of
MS patients. More studies are needed to determine
the factors that positively affect QoL of MS
patients.
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